Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2021/05/11/2227066/0/en/WPD-Pharmaceuticals-to-Receive-6-7-Million-Grant-for-Development-of-Annamycin-Drug-Candidate.html#:~:text=(CSE%3A%20WBIO)(FSE%3A,of%20Annamycin%2C%20the%20Company's%20drug
https://www.globenewswire.com/news-release/2021/04/27/2217556/0/en/WPD-Pharmaceuticals-to-Attend-the-10th-Congress-of-the-Polish-Society-of-Pediatric-Oncology-and-Hematology-and-Present-Assumption-of-the-Phase-1-Study-with-Berubicin-in-Pediatric-M.html
http://www.globenewswire.com/news-release/2021/03/30/2201457/0/en/WPD-Pharmaceuticals-Announces-Amended-Sublicense-Agreement-with-Moleculin-Biotech-for-WP1066-WP1122-and-Annamycin-Drug-Candidates.html?f=22&fvtc=5&fvtv=32375057#:~:text=On%20March%2022%2C%202021%2C%20WPD,derived%20from%20these%20portfolios%20in
https://www.globenewswire.com/news-release/2021/02/18/2178169/0/en/WPD-and-CNS-Pharmaceuticals-Announce-Positive-Opinion-of-the-Polish-Central-Ethics-Committee-for-the-WPD-201-Study-and-Central-IRB-Study-Level-Approval-for-the-CNS-201-Study.html
https://www.globenewswire.com/news-release/2020/08/17/2079327/0/en/WPD-Pharmaceuticals-Enters-into-Collaborative-Agreement-for-WP1122-Receives-Supply-and-Appoints-New-CFO.html
https://www.prnewswire.com/news-releases/cns-pharmaceuticals-and-wpd-pharmaceuticals-identify-leading-polish-medical-institutions-for-berubicin-phase-2-clinical-trial-301050028.html
https://www.prnewswire.com/news-releases/cns-pharmaceuticals-announces-shareholder-webinar-to-discuss-collaboration-with-wpd-pharmaceuticals-for-developing-coronavirus-drug-candidates-the-significance-of-wp1244-and-an-update-on-the-cancer-free-survivor-treated-with-ber-301040816.html
https://www.globenewswire.com/news-release/2020/04/09/2014074/0/en/WPD-Pharmaceuticals-Reports-Active-Compound-in-Licensed-Drug-Candidate-Reduces-Coronavirus-Replication-in-Vitro-by-100.html
https://www.prnewswire.com/news-releases/cns-pharmaceuticals-signs-agreement-with-wpd-pharmaceuticals-to-develop-drug-candidates-for-a-range-of-viruses-including-coronavirus-for-international-markets-301027803.html
https://www.globenewswire.com/news-release/2020/02/20/1987583/0/en/WPD-Pharmaceuticals-STAT3-Inhibitor-Received-FDA-Approval-of-IND-Status-in-Pediatric-Brain-Cancer-Trial.html